MedPath

Naloxone Hydrochloride

Naloxone Hydrochloride Injection, USP Rx only

Approved
Approval ID

5de44ee7-6525-4857-9a67-8882e96dbeb5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 17, 2023

Manufacturers
FDA

BPI Labs LLC

DUNS: 078627620

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Naloxone Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54288-124
Application NumberANDA216977
Product Classification
M
Marketing Category
C73584
G
Generic Name
Naloxone Hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS
Effective DateOctober 17, 2023
FDA Product Classification

INGREDIENTS (4)

NALOXONE HYDROCHLORIDEActive
Quantity: 1 mg in 1 mL
Code: F850569PQR
Classification: ACTIM
SODIUM CHLORIDEInactive
Quantity: 8.35 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Naloxone Hydrochloride - FDA Drug Approval Details